Terfenadine is a H1-receptor antagonist that has been substituted for its former analogs in the treatment of allergic rhinitis, urticaria and asthma. Because of its little effects on central nervous system, its use has been widely increased. In this study eleven different formulations, for preparation a terfenadine tablet by wet granulation, dry granulation and direct compression methods using various excipients including dibasic calcium phosphate, sorbitol, calcium carbonate and microcrystalline cellulose (as diluents), povidone, starch paste, methyl cellulose and veegum (as binding agents), sodium starch glycolate, sodium bicarbonate and starch (as disintegrants), talc, sodium lauryl sulphate and magnesium stearate (as lubricating agents) were obtained. Control tests on powder mixture before compression, and physicochemical and accelerated stability (Arhenius method) tests on final tablets were also done. According to the results obtained it seemed that one of the formulation for direct compression as compared to other formulations prepared experimentally and also generic formulation prepared in Iran and another commercial product, was preferred from the physicochemical and economic points of view such as weight variation, hardness, dissolution test, dissolution rate and the final price of product.